AAAAAA
Results:
1-16
|
Results: 16
Authors:
de Sevaux, RGL
Gregoor, PJHS
Hene, RJ
Hoitsma, AJ
Vos, P
Weimar, W
van Gelder, T
Hilbrands, LB
Citation: Rgl. De Sevaux et al., A controlled trial comparing two doses of cyclosporine in conjunction withmycophenolate mofetil and corticosteroids, J AM S NEPH, 12(8), 2001, pp. 1750-1757
Authors:
Ligtenberg, G
Hene, RJ
Blankestijn, PJ
Koomans, HA
Citation: G. Ligtenberg et al., Cardiovascular risk factors in renal transplant patients: Cyclosporin A versus tacrolimus, J AM S NEPH, 12(2), 2001, pp. 368-373
Authors:
Stevens, H
de Klerk, JMH
Mertens, IJR
van Rijk, PP
Hene, RJ
Citation: H. Stevens et al., Quantitative baseline renography 48 hours after renal transplantation predicts long-term graft survival, EUR J NUCL, 28(11), 2001, pp. 1677-1681
Authors:
Schrama, YC
van Dam, T
Fijnheer, R
Hene, RJ
de Groot, P
Rabelink, TJ
Citation: Yc. Schrama et al., Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation, NETH J MED, 59(1), 2001, pp. 6-15
Authors:
van der Vliet, JA
Kievit, JK
Hene, RJ
Hilbrands, LB
Kootstra, G
Citation: Ja. Van Der Vliet et al., Preservation of non-heart-beating donor kidneys: A clinical prospective randomised case-control study of machine perfusion versus cold storage, TRANSPLAN P, 33(1-2), 2001, pp. 847-847
Authors:
ter Meulen, CG
Baan, CC
Hene, RJ
Hilbrands, LB
Hoitsma, AJ
Citation: Cg. Ter Meulen et al., Two doses of daclizumab are sufficient for prolonged interleukin-2R alpha chain blockade, TRANSPLANT, 72(10), 2001, pp. 1709-1710
Authors:
Schrama, YC
de Haas, ERM
Hene, RJ
Citation: Yc. Schrama et al., Concealed by veils, NEPH DIAL T, 15(2), 2000, pp. 259-261
Authors:
Schrama, YC
Joles, JA
van Tol, A
Boer, P
Koomans, HA
Hene, RJ
Citation: Yc. Schrama et al., Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients, TRANSPLANT, 69(3), 2000, pp. 376-383
Authors:
Boer, WH
Hene, RJ
Citation: Wh. Boer et Rj. Hene, Lethal air embolism following removal of a double lumen jugular vein catheter, NEPH DIAL T, 14(8), 1999, pp. 1850-1852
Authors:
Koomans, HA
Beutler, JJ
Hene, RJ
Citation: Ha. Koomans et al., Nephrology at the turn of the century: a preview, NETH J MED, 55(6), 1999, pp. 304-309
Authors:
van Gelder, T
Hilbrands, LB
Vanrenterghem, Y
Weimar, W
de Fijter, JW
Squifflet, JP
Hene, RJ
Verpooten, GA
Navarro, MT
Hale, MD
Nicholls, AJ
Citation: T. Van Gelder et al., A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation, TRANSPLANT, 68(2), 1999, pp. 261-266
Authors:
Gregoor, PJHS
de Sevaux, RGL
Hene, RJ
Hesse, CJ
Hilbrands, LB
Vos, P
van Gelder, T
Hoitsma, AJ
Weimar, W
Citation: Pjhs. Gregoor et al., Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients, TRANSPLANT, 68(10), 1999, pp. 1603-1606
Authors:
Bakker, J
Ligtenberg, G
Beek, FJA
van Reedt Dortland, RWH
Hene, RJ
Citation: J. Bakker et al., Preoperative evaluation of living renal donors with gadolinium-enhanced magnetic resonance angiography, TRANSPLANT, 67(8), 1999, pp. 1167-1172
Authors:
Hes, FJ
Slootweg, PJ
van Vroonhoven, TJMV
Hene, RJ
Feldberg, MAM
Zewald, RA
van Amstel, JKP
Hoppener, JWM
Pearson, PL
Lips, CJM
Citation: Fj. Hes et al., Management of renal cell carcinoma in von Hippel-Lindau disease, EUR J CL IN, 29(1), 1999, pp. 68-75
Authors:
van der Plas, RM
Schiphorst, ME
Huizinga, EG
Hene, RJ
Verdonck, LF
Sixma, JJ
Fijnheer, R
Citation: Rm. Van Der Plas et al., von Willebrand factor proteolysis is deficient in classic, but not in bonemarrow transplantation-associated, thrombotic thrombocytopenic purpura, BLOOD, 93(11), 1999, pp. 3798-3802
Authors:
Padberg, M
Rinkel, GJE
Hene, RJ
Rabelink, TJ
Citation: M. Padberg et al., A winking warning, NEPH DIAL T, 13(12), 1998, pp. 3263-3264
Risultati:
1-16
|